Trademarkia Logo

Canada

C$
NMD & DESIGN
REGISTERED

on 7 Nov 2022

Last Applicant/ Owned by

NMD PHARMA A/S

Palle Juul-Jensens Boulevard 82Aarhus N, DK-8200

DK

Serial Number

1903334 filed on 8th Jun 2018

Registration Number

TMA1149755 registered on 7th Nov 2022

Registration expiry Date

7th Nov 2032

Correspondent Address

FURMAN IP LAW & STRATEGY PC

260-10 Research DriveOffice D/EREGINA

SASKATCHEWAN

CA

S4S7J7

NMD & DESIGN

Trademark usage description

diagnostic preparations for medical purposes, namely for use in the diagnosis and treatment of human neuromuscular and neurodegenerative conditions an Read More

Vienna Information


26 . 4 . 3

Rhombs or squares standing on one of the corners thereofLosanges ou carrés sur pointe

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

Classification Information


Class [005]
Diagnostic preparations for medical purposes, namely for use in the diagnosis and treatment of human neuromuscular and neurodegenerative conditions and disorders; diagnostic reagents for medical use, namely for use in the diagnosis and treatment of human neuromuscular and neurodegenerative conditions and disorders; pharmaceutical preparations for the treatment of human neurodegenerative diseases and human neuromuscular disorders; pharmaceutical and medical preparations that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders


Classification kind code

11

Class [042]
Scientific and technological services and research, namely product research and development in the field of treatment of human neuromuscular and neurodegenerative conditions and disorders; industrial analysis and research services, namely product research and development in the field of treatment of human neuromuscular and neurodegenerative conditions and disorders; drug discovery services, namely development of pharmaceutical compounds and drug treatments in the field of treatment of human neuromuscular and neurodegenerative conditions and disorders; basic research and clinical research, hereunder for medicine and vaccine development; development of medical treatments related to rare and genetic diseases; development of medical treatments related to neurodegenerative diseases; development of medical treatments related to neuromuscular disorders; development of medical treatments that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; development of medical treatments for acute hospital care


Classification kind code

11

Mark Details


Serial Number

1903334

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 6th Jul 2022
Advertised
Submitted for opposition 26
on 2th May 2022
Approved
Submitted for opposition 27
on 2th May 2022
Approval Notice Sent
Submitted for opposition 12
on 5th Oct 2021
Extension of Time
Submitted for opposition 15
on 19th Mar 2021
Correspondence Created
Submitted for opposition 22
on 28th May 2020
Search Recorded
Submitted for opposition 20
on 28th May 2020
Examiner's First Report
Submitted for opposition 31
on 11th Jun 2018
Formalized
Submitted for opposition 30
on 8th Jun 2018
Filed
Submitted for opposition 1
on 8th Jun 2018
Created